I am searching for more information on GPI-1046 - a very new "neurotrophic factor" drug manufactured by Guilford Pharmaceuticals, Baltimore. This new class of drug has been shown to "revive damadged nerves and eliminate most symptoms of disease in laboratory animals with Parkinson's-like symptoms." Article in the April 16,1997 Wall Street Journal titled "Nerve Regenerating Drug May Help in Alzheimer's, Parkinson's Diseases". Results were presented at a meeting of the American chemical Society recently. Does anyone have furthur information regarding preliminary drug trials, other studies, Journal references? Thanks, /s/ Millard Tipp - NPF, S.California